Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL

Alcon

Status and phase: Completed; Phase 4

Conditions: Cataracts

Treatments: Device: AcrySof ReSTOR Aspheric IOL

Study type: Interventional

Funder types: Industry

Identifiers

NCT00818116

CH-08-001

Details and patient eligibility

About

The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).

Enrollment: 34 patients

Sex: All

Ages: 50 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation.
• 50~75 years of age
• <1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings.

Exclusion criteria

• Patients with pre-existing conditions that could skew the results.
• Any of conditions before and during surgery specified in the product information.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

34 participants in 1 patient group

ReSTOR Aspheric IOL

Experimental group

Description:

Bilateral implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL)

Treatment:

Device: AcrySof ReSTOR Aspheric IOL